We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Due this month - May 2024.
See:-
https://angleplc.com/information-for-investors-angle-plc/financial-reports/#text_grid-1
Yes they were shocking...I did say a placement was on the cards.. imho.
????
I was thinking 10p at best!
TwoGood2Die.
I don't mean for the whole Company. LOL!
Hello.
Pretty obvious the market doesn't agree with the desperate rampers here!
Https://www.lse.co.uk/ShareBrokerTips.html?shareprice=AGL&share=Angle
Slowly all pharma's are getting delisted as they are under valued. Redx got delisted yesterday. Dyor
Also looks like seller out. This should now move. Also trading update coming any day. Dyor
Broker Rating 70p. What's not to like.
And 474 parsortix blood samples analysed so at least £474k in the coffers….
Https://onlinelibrary.wiley.com/doi/full/10.1002/ijc.34978
Just look at the Companies mentioned in this article:-
***Elena Ioana Braicu receives research funding from Bayer, Roche Diagnostics, Tesaro, GSK, and AstraZeneca and personal fees from AstraZeneca, Clovis, GSK, Tesaro, EISAI, RochePharma, and Roche Diagnostics. Elena Ioana Braicu is a Feodor Lynen fellow of the Humboldt Foundation and a participant in the Charité Clinical Scientist Program funded by the Charité Universitätsmedizin Berlin and the Berlin Institute of Health.
***Philipp Harter receives research funding from Astra Zeneca, Roche, GSK, Genmab, DFG, European Union, DKH, Immunogen, Seagen, Clovis, and Novartis and honoraria from Amgen, Astra Zeneca, GSK, Roche, Sotio, Stryker, Zai Lab, MSD, Clovis, Eisai, Mersana, and Exscientia.
***Philipp Harter is ******an advisory board member******* for Astra Zeneca, Roche, GSK, Clovis, Immunogen, MSD, Miltenyi, Novartis, and Eisai!!!!!!!!!!!!!!!*************.
All IMHO.
Agl will go like redx. Bod will take this out of aim
Trading update due and also updates on other contracts. Gla
I see these hitting 20.00 + in the short term and bought some more
250000 buy printed from last friday . Peep paid 15.15.
TGTD - Angle don't need 6m in new customer contracts to meet the 6m revenue target. As well as the new contracts they have:-
- A base of existing lab services customers from 2023 whose work extends into 2024 (and may well have follow on contracts already in place).
- Parsortix device & cassette sales which will also be generating revenue (they aren't going to announce the sale of each machine)
- Other product sales (the new kit)
The new customer announcement are just one part of the revenue picture. Hopefully we will get some good insight into the scale / trajectory of the bigger picture in the imminent results.
Loads….yet you sold shares last, as you (claimed) you did when it was. >18p
What’s your average here EC?
One wonders what others are in the pipeline.
There are thousands of Pharma Co's IN THE WORLD. Food for thought TwoGood2Die, is it not!!! LOL!
I think there will be LOADS in the next 4 months. LOADS.
All IMHO.
The Board really should demand that Newland’s salary be cut back as he persists in misleading investors. Outrageous that he was allowed to stick his finger in the air and guess at a tripling of revenues and then provide absolutely no solid reasoning as to why.
Nearly half the year gone and no sign of the £6m in order to extend the cash runway to Q2 next year.
It was around this time last year that the last cash placement was raised!
Miavoce
Revenue is cash at the end of the day is it not?
The company have confirmed there’s a funding gap. It would be very optimistic to think that since Novembers trading update we’ve not only found the trebling £6m of revenue, but surpassed that to such an extent that we’ve extended the runway. We are indeed speculating about the performance this year but there’s no RNS to point to around material revenue. I suspect we won’t hit the £6m and thus the runway is shorter.